Bridgefront Capital »

Arcutis Biotherapeutics shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $310k 12k 26.22

More positions owned by Bridgefront Capital

Colgate-Palmolive Company (CL)
Kimberly-Clark Corporation (KMB)
Tyson Foods Cl A (TSN)
Constellation Brands Cl A (STZ)
Lauder Estee Cos Cl A (EL)
Coca-Cola Company (KO)
Molson Coors Beverage CL B (TAP)
American Tower Reit (AMT)
Agree Realty Corporation (ADC)
Wells Fargo & Company (WFC)
Trane Technologies SHS (TT)
Occidental Petroleum Corporation (OXY)
Halliburton Company (HAL)
Citigroup Com New (C)
Spectrum Brands Holding (SPB)

View all positions for Bridgefront Capital

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Rubric Capital Management
Polar Capital Holdings
State Street Corporation
Vanguard Capital Management
Jennison Associates
Morgan Stanley
D. E. Shaw & Co
UBS Group
Bank of America Corporation
Geode Capital Management
Vanguard Portfolio Management
OrbiMed Advisors

View all funds holding Arcutis Biotherapeutics